Good News Pours In For Oncomed Pharmaceuticals Inc (NASDAQ:OMED)

Boston, MA 09/08/2014 (wallstreetpr) – Oncomed Pharmaceuticals Inc (NASDAQ:OMED) announced that it had got relief from the holds of FDA on its ipafricept (FZD8-Fc, OMP-54F28) Phase 1 clinical trials. The clinical trials were facing partial clinical holds from the U.S. Food and Drug Administration. Oncomed can start with its enrollment process and dosing of new […]